Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Longeveron Inc (NQ: LGVN ) 3.900 +0.380 (+10.80%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 17, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Longeveron Inc < Previous 1 2 3 4 5 6 7 8 9 ... 14 15 Next > Scientists Discover Alzheimer’s Can Be Categorized into Five Subtypes January 18, 2024 Via Investor Brand Network Five Significant Strides Made in Alzheimer’s Research in 2023 January 05, 2024 Via Investor Brand Network Lineage Cell Therapeutics, Longeveron And 2 Other Stocks Under $2 Insiders Are Buying January 03, 2024 The Dow Jones index closed higher by around 25 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... Via Benzinga Topics Stocks Exposures US Equities Studies Suggest Fasting Could Tone Down Alzheimer’s Signs December 22, 2023 Via Investor Brand Network BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Enters Definitive Agreement for $2.36M Registered Direct Offering December 21, 2023 Via Investor Brand Network Why Longeveron (LGVN) Shares Are Falling Sharply December 21, 2023 Longeveron Inc (NASDAQ: LGVN) shares are trading lower by 22.8% to $1.25 Thursday morning after the company has finalized an agreement for a Via Benzinga Earnings Preview: Longeveron November 09, 2023 Via Benzinga Nasdaq Gains 100 Points; CarMax Earnings Top Views December 21, 2023 U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 100 points on Thursday. The Dow traded up 0.37% to 37,218.15 while the NASDAQ rose 0.73% to 14,885.76.... Via Benzinga Topics Stocks Exposures US Equities Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session December 21, 2023 Shares of CarMax, Inc. (NYSE: KMX) moved higher during Thursday’s session following better-than-expected quarterly earnings. Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session December 21, 2023 Via Benzinga Crude Oil Moves Lower; Micron Issues Strong Forecast December 21, 2023 U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Thursday. The Dow traded up 0.58% to 37,296.40 while the NASDAQ rose 0.77% to 14,891.87. The... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Reports Additional Positive Clinical Data, Imaging Biomarker Results in Phase 2a Lomecel-B(TM) Trial December 20, 2023 Via Investor Brand Network 12 Health Care Stocks Moving In Wednesday's Pre-Market Session December 20, 2023 Via Benzinga Smart Trackers Could Detect Aging-Related Complications in Seniors December 12, 2023 Via Investor Brand Network Longeveron (NASDAQ: LGVN) Announces Positive Top-Line Results For Its Phase 2a Clinical Trial For The Treatment Of Mild Alzheimer’s Disease With Lomecel-B™ December 06, 2023 --News Direct-- Via News Direct 12 Health Care Stocks Moving In Tuesday's After-Market Session December 05, 2023 Via Benzinga Longeveron (NASDAQ: LGVN) Announces Positive Top-Line Results For Its Phase 2a Clinical Trial For The Treatment Of Mild Alzheimer's Disease with Lomecel-B™ December 05, 2023 Longeveron Inc. (NASDAQ: LGVN), a clinical-stage biotech company aiming to address life-threatening and chronic aging-related conditions using cell therapies, continues to make positive progress. Via Benzinga BioMedNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) Eyes ‘Encouraging’ Results from CLEAR MIND Trial December 01, 2023 Via Investor Brand Network Hidden Belly Fat Could Be a Precursor of Alzheimer’s Onset Years Later November 30, 2023 Via Investor Brand Network Longeveron Inc. (NASDAQ: LGVN) Encouraged by Positive Results from Phase 2a Trial in Patients with Mild AD; Explores Paths Forward for the Development of Lomecel-B(TM) November 21, 2023 Via Investor Brand Network Study Links Cat Parasite to Accelerated Frailty in Aging People November 16, 2023 Via Investor Brand Network BioMedNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) Featured in Bell2Bell Podcast November 14, 2023 Via Investor Brand Network BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN; LGVNR) Study Survival Data Reported at AHA’s 2023 Scientific Sessions November 13, 2023 Via Investor Brand Network BioMedNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) Announces 2023 Results, Provides Corporate Update November 10, 2023 Via Investor Brand Network Earnings Scheduled For November 10, 2023 November 10, 2023 Companies Reporting Before The Bell • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter. Via Benzinga Sex Hormones Could Influence Alzheimer’s Development, Researchers Say November 06, 2023 Via Investor Brand Network BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN; LGVNR) Announces Plans to Release Q3 2023 Financial Report, Host Corporate Update Call November 03, 2023 Via Investor Brand Network Longeveron Inc. (NASDAQ: LGVN) Validates Safety and Therapeutic Potential of its Lomecel-B(TM) Lead Investigational Product in its CLEAR MIND Phase 2a Clinical Trial October 30, 2023 Via Investor Brand Network BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN; LGVNR) Top-Line Results from Phase 2a Trial Spotlighted in Latest NNA Release October 24, 2023 Via Investor Brand Network Nearly A Third Of Japan’s 36 Million Seniors Are At Risk Of Aging Frailty – Could Lomecel-BTM, Longeveron’s (NASDAQ: LGVN) Cell Therapy Help? October 24, 2023 --News Direct-- Via News Direct < Previous 1 2 3 4 5 6 7 8 9 ... 14 15 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.